| Dr Michael Thomas Wright, MD | |
|
5770 S 300 E, Murray, UT 84107-6548 | |
| (801) 314-2730 | |
| (801) 314-2029 |
| Full Name | Dr Michael Thomas Wright |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 5770 S 300 E, Murray, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376502666 | NPI | - | NPPES |
| 870326048001D2530 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 287019-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Lds Hospital | Salt lake city, UT | Hospital |
| Riverton Hospital | Riverton, UT | Hospital |
| Utah Valley Hospital | Provo, UT | Hospital |
| American Fork Hospital | American fork, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Utah Pathology Services Inc | 1355251521 | 27 |
News Archive
One of the most dangerous characteristics of cancer is its ability to metastasize, or spread through the body. For this reason, oncologists have a major need for better tests to detect cells that break away from primary tumors to travel to other parts of the body.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).
The Visiting Nurse Service of New York, the nation's largest not-for-profit home health care organization, announced today that it has successfully bid for, and is set to acquire, the Long Term Home Health Care Program from St. Vincent's Catholic Medical Center. The transaction was filed at a closed, one-time bid auction on August 10, 2010. The purchase price of $30,150,000 is pending approval by the U.S. Bankruptcy Court and the Attorney General's Office.
Mount Sinai researchers have discovered that microglia, the immune cells that reside in the brain, have a unique origin and are formed shortly after conception. It was previously thought that microglia originated at the same time as macrophages, which are other immune cells that are thought to develop at birth. This groundbreaking discovery has the potential to lead to future treatments of degenerative brain diseases such as Alzheimer's and autoimmune diseases such as multiple sclerosis. The study is published online October 21 in Science Express.
› Verified 3 days ago
| Entity Name | Utah Pathology Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134188998 PECOS PAC ID: 1355251521 Enrollment ID: O20031208000678 |
News Archive
One of the most dangerous characteristics of cancer is its ability to metastasize, or spread through the body. For this reason, oncologists have a major need for better tests to detect cells that break away from primary tumors to travel to other parts of the body.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).
The Visiting Nurse Service of New York, the nation's largest not-for-profit home health care organization, announced today that it has successfully bid for, and is set to acquire, the Long Term Home Health Care Program from St. Vincent's Catholic Medical Center. The transaction was filed at a closed, one-time bid auction on August 10, 2010. The purchase price of $30,150,000 is pending approval by the U.S. Bankruptcy Court and the Attorney General's Office.
Mount Sinai researchers have discovered that microglia, the immune cells that reside in the brain, have a unique origin and are formed shortly after conception. It was previously thought that microglia originated at the same time as macrophages, which are other immune cells that are thought to develop at birth. This groundbreaking discovery has the potential to lead to future treatments of degenerative brain diseases such as Alzheimer's and autoimmune diseases such as multiple sclerosis. The study is published online October 21 in Science Express.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Thomas Wright, MD Po Box 30309, Charleston, SC 29417-0309 Ph: (843) 554-9300 | Dr Michael Thomas Wright, MD 5770 S 300 E, Murray, UT 84107-6548 Ph: (801) 314-2730 |
News Archive
One of the most dangerous characteristics of cancer is its ability to metastasize, or spread through the body. For this reason, oncologists have a major need for better tests to detect cells that break away from primary tumors to travel to other parts of the body.
The Second Annual Science Writers Symposium on Nov. 4 and 5, 2009, at the FDA's White Oak campus in Silver Spring, Md., will highlight how the FDA applies novel scientific approaches to critical public health issues and the products it regulates. The symposium, featuring a lab tour and presentations by FDA scientists, will give writers a unique insight into the evolving field of regulatory science with an eye towards generating potential story ideas.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).
The Visiting Nurse Service of New York, the nation's largest not-for-profit home health care organization, announced today that it has successfully bid for, and is set to acquire, the Long Term Home Health Care Program from St. Vincent's Catholic Medical Center. The transaction was filed at a closed, one-time bid auction on August 10, 2010. The purchase price of $30,150,000 is pending approval by the U.S. Bankruptcy Court and the Attorney General's Office.
Mount Sinai researchers have discovered that microglia, the immune cells that reside in the brain, have a unique origin and are formed shortly after conception. It was previously thought that microglia originated at the same time as macrophages, which are other immune cells that are thought to develop at birth. This groundbreaking discovery has the potential to lead to future treatments of degenerative brain diseases such as Alzheimer's and autoimmune diseases such as multiple sclerosis. The study is published online October 21 in Science Express.
› Verified 3 days ago
Dr. William Dean Wallace, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 747 W 4170 S, Murray, UT 84123 Phone: 801-260-6015 | |
Dr. James Richard Farnsworth, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5252 S Intermountain Dr, Murray, UT 84107 Phone: 801-507-2110 Fax: 801-408-5196 | |
Dylan V Miller, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5252 S Intermountain Dr, Murray, UT 84107 Phone: 801-507-2150 Fax: 801-507-2311 | |
Dr. J Manuel Zarandona, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5121 Cottonwood St, Intermountain Medical Center Dept. Of Pathology, Murray, UT 84107 Phone: 801-507-7970 Fax: 801-507-7996 |